Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Bases de datos
Tipo de estudio
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Cell Mol Life Sci ; 78(10): 4735-4763, 2021 May.
Artículo en Inglés | MEDLINE | ID: mdl-33792748

RESUMEN

Neuronal Ceroid Lipofuscinosis (NCL), also known as Batten disease, is an incurable childhood brain disease. The thirteen forms of NCL are caused by mutations in thirteen CLN genes. Mutations in one CLN gene, CLN5, cause variant late-infantile NCL, with an age of onset between 4 and 7 years. The CLN5 protein is ubiquitously expressed in the majority of tissues studied and in the brain, CLN5 shows both neuronal and glial cell expression. Mutations in CLN5 are associated with the accumulation of autofluorescent storage material in lysosomes, the recycling units of the cell, in the brain and peripheral tissues. CLN5 resides in the lysosome and its function is still elusive. Initial studies suggested CLN5 was a transmembrane protein, which was later revealed to be processed into a soluble form. Multiple glycosylation sites have been reported, which may dictate its localisation and function. CLN5 interacts with several CLN proteins, and other lysosomal proteins, making it an important candidate to understand lysosomal biology. The existing knowledge on CLN5 biology stems from studies using several model organisms, including mice, sheep, cattle, dogs, social amoeba and cell cultures. Each model organism has its advantages and limitations, making it crucial to adopt a combinatorial approach, using both human cells and model organisms, to understand CLN5 pathologies and design drug therapies. In this comprehensive review, we have summarised and critiqued existing literature on CLN5 and have discussed the missing pieces of the puzzle that need to be addressed to develop an efficient therapy for CLN5 Batten disease.


Asunto(s)
Proteínas de Membrana de los Lisosomas/genética , Lisosomas/metabolismo , Mutación , Lipofuscinosis Ceroideas Neuronales/patología , Animales , Humanos , Proteínas de Membrana de los Lisosomas/metabolismo , Lipofuscinosis Ceroideas Neuronales/etiología , Lipofuscinosis Ceroideas Neuronales/metabolismo
3.
Gene Ther ; 22(5): 357-64, 2015 May.
Artículo en Inglés | MEDLINE | ID: mdl-25630949

RESUMEN

Lentiviral vectors have proved an effective method to deliver transgenes into the brain; however, they are often hampered by a lack of spread from the site of injection. Modifying the viral envelope with a portion of a rabies envelope glycoprotein can enhance spread in the brain by using long-range axon projections to facilitate retrograde transport. In this study, we generated two chimeric envelopes containing the extra-virion and transmembrane domain of rabies SADB19 or CVS-N2c with the intra-virion domain of vesicular stomatitis virus. Viral particles were packaged containing a green fluorescent protein reporter construct under the control of the phosphoglycerokinase promoter. Both vectors produced high-titer particles with successful integration of the glycoproteins into the particle envelope and significant transduction of neurons in vitro. Injection of the SADB19 chimeric viral vector into the lumbar spinal cord of adult mice mediated a strong preference for gene transfer to local neurons and axonal terminals, with retrograde transport to neurons in the brainstem, hypothalamus and cerebral cortex. Development of this vector provides a useful means to reliably target select populations of neurons by retrograde targeting.


Asunto(s)
Transporte Axonal , Técnicas de Transferencia de Gen , Lentivirus/genética , Virus de la Rabia/genética , Médula Espinal/citología , Vesiculovirus/genética , Proteínas del Envoltorio Viral/genética , Animales , Células Cultivadas , Vectores Genéticos/genética , Glicerol Quinasa/genética , Proteínas Fluorescentes Verdes/genética , Proteínas Fluorescentes Verdes/metabolismo , Ratones , Ratones Endogámicos C57BL , Neuronas/metabolismo , Regiones Promotoras Genéticas , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Médula Espinal/metabolismo , Proteínas del Envoltorio Viral/metabolismo
4.
Brain Struct Funct ; 223(7): 3213-3228, 2018 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-29796923

RESUMEN

Early during their maturation, adult-born dentate granule cells (aDGCs) are particularly excitable, but eventually develop the electrophysiologically quiet properties of mature cells. However, the stability versus plasticity of this quiet state across time and experience remains unresolved. By birthdating two populations of aDGCs across different animal ages, we found for 10-month-old rats the expected reduction in excitability across cells aged 4-12 weeks, as determined by Egr1 immunoreactivity. Unexpectedly, cells 35 weeks old (after genesis at an animal age of 2 months) were as excitable as 4-week-old cells, in the dorsal hippocampus. This high level of excitability at maturity was specific for cells born in animals 2 months of age, as cells born later in life did not show this effect. Importantly, excitability states were not fixed once maturity was gained, but were enhanced by enriched environment exposure or LTP induction, indicating that any maturational decrease in excitability can be compensated by experience. These data reveal the importance of the animal's age for aDGC excitability, and emphasize their prolonged capability for plasticity during adulthood.


Asunto(s)
Envejecimiento/fisiología , Conducta Animal , Giro Dentado/fisiología , Neurogénesis , Plasticidad Neuronal , Neuronas/fisiología , Potenciales de Acción , Factores de Edad , Animales , Biomarcadores/metabolismo , Senescencia Celular , Giro Dentado/citología , Giro Dentado/metabolismo , Proteína 1 de la Respuesta de Crecimiento Precoz/metabolismo , Vivienda para Animales , Potenciación a Largo Plazo , Masculino , Actividad Motora , Neuronas/metabolismo , Ratas Sprague-Dawley , Conducta Social
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA